Ventavia Research Group Revenue and Competitors

Ventavia Research Group was established by a vision to create a research company that would provide exceptional services to the clinical trial industry. This vision included three key factors: producing the highest quality data, ensuring subject safety, and only hiring professionals with unmeasurable integrity. Based in the Dallas/Fort Worth metroplex, Ventavia Research Group serves as a comprehensive, multi-therapeutic research organization for inpatient and outpatient trials Phases I-IV. We pride ourselves in efficient turnaround time for all start-up activities such as regulatory submissions and contract/budgets negotiations. Our subject recruitment methods include an involved method of pre-screening to ensure good, quality subjects are participating. Our staff and investigators adhere to all ICH GCP standards and are committed to expedited data entry, in-house quality assurance, prioritizing subject safety, and maintaining a high level of professionalism through the entire process. In the development of new medications, Ventavia Research Group understands the investigative site’s role is vital. We embrace all challenges and opportunities that arise within clinical research and are dedicated to ensuring each trial is conducted with the highest industry standards. Ventavia Research is proud to now house 3 different locations, with new additions in Hurst and Houston, TX. Fort Worth, TX - Dr. Isaac Watemberg; Manager, Mercedes Livingston. Houston, TX - Dr. Karita Shah Patel; Managers, Lilly Buckins and Ramona Irizarry. Hurst, TX - Dr. Tho Quoc Nguyen; Manager, Mercedes Livingston.